Drug intelligence / Profile preview

Polyherb B

Development stage: Unknown
Administration: Oral

Overview

Polyherb B is an Ayurvedic herbal formulation composed of *Tinospora cordifolia* and *Zingiber officinale*. It has been investigated for the treatment of active moderately severe rheumatoid arthritis (RA), demonstrating comparable efficacy to hydroxychloroquine sulfate (HCQS) in an exploratory clinical trial. The formulation is derived from ancient Indian medicinal systems and is considered a potentially safer alternative to conventional disease-modifying antirheumatic drugs (DMARDs).

Beyond the preview

Go deeper on Polyherb B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyherb B.

Explore the full profile